Multiple ovarian antral follicles in a preterm infant with neonatal intrahepatic cholestasis caused by citrin deficiency: a clinical, genetic and transcriptional analysis.
Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is an autosomal recessive disease caused by the dysfunction of citrin, an aspartate/glutamate carrier encoded by the SLC25A13 gene. Considerable progress has been made on the diagnosis and treatment of NICCD, but its clinical and molecular features still remain far from being completely elucidated and generally understood. The infant, a preterm female delivered at a gestational age of 31 weeks, was referred to our hospital at the age of 8 months because of jaundice lasting for 4.5 months and ovarian masses uncovered for 3 months. Besides serum indices indicating cholestasis, elevated serum levels of luteinizing hormone, follicle stimulating hormone and estradiol were also detected. Abdominal magnetic resonance imaging demonstrated bilateral multi-cystic ovarian masses, with the largest size being 7.4 × 6.2 × 9.6 mm(3). SLC25A13 gene analysis revealed that the patient was a compound heterozygote of c.1177+1G>A and c.754G>A. The paternally-inherited mutation c.754G>A was a novel one with a carrier rate of less than 1%. SLC25A13 transcriptional study in peripheral blood lymphocytes (PBLs) documented a novel splice variant r.616_848del which resulted from c.754G>A, with another variant r.1019_1177del from the maternally-inherited c.1177+1G>A mutation. The diagnoses were NICCD and multiple ovarian antral follicles (minipuberty), and the patient responded well to a galactose-free and medium chain triglyceride (MCT)-enriched formula. The findings in this paper expanded the clinical and molecular spectrum of the SLC25A13 gene, and lent support to the concept that PBLs could be taken as a feasible specimen source for SLC25A13 transcriptional analysis.
Department of Pediatrics, The First Affiliated Hospital, Jinan University, Guangzhou 510630, China.
Wei-Xia
WX
Lin
Zhan-Hui
ZH
Zhang
Mei
M
Deng
Xiang-Ran
XR
Cai
Yuan-Zong
YZ
Song
D002135:Calcium-Binding Proteins / Q000235:genetics*; D020159:Citrullinemia / Q000097:blood / Q000175:diagnosis / Q000178:diet therapy / Q000235:genetics* / Q000378:metabolism*; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007986:Luteinizing Hormone / Q000097:blood; D008214:Lymphocytes / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D009154:Mutation; D027361:Organic Anion Transporters / Q000235:genetics*; D010048:Ovarian Cysts / Q000097:blood / Q000175:diagnosis / Q000178:diet therapy / Q000235:genetics / Q000378:metabolism; D006080:Ovarian Follicle / Q000503:physiopathology*; D014158:Transcription, Genetic; D016896:Treatment Outcome; D014280:Triglycerides / Q000627:therapeutic use
D002135:Calcium-Binding Proteins; D027361:Organic Anion Transporters; D014280:Triglycerides; C008822:citrin; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone